1-碘-4-(4-甲基苯氧基)苯 | 1017793-91-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-碘-4-(4-甲基苯氧基)苯
• 英文名称: 4-(4-Methylphenoxy)iodobenzene
• 英文别名: 1-iodo-4-(4-methylphenoxy)benzene
• CAS: 1017793-91-7
• 化学式: C₁₃H₁₁IO
• mdl: MFCD06796301
• 分子量: 310.134
• InChiKey: VLFXLXIIUUXNFE-UHFFFAOYSA-N

物化性质

• 沸点：
  332.0±25.0 °C(Predicted)
• 密度：
  1.563±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-碘-4-(4-甲基苯氧基)苯 、 1-己炔 在 copper(l) iodide 、 四(三苯基膦)钯 、 三乙胺 作用下， 反应 18.0h， 以90%的产率得到1-(hex-1-yn-1-yl)-4-(p-tolyloxy)benzene
  参考文献：
  名称：

  Cu-Catalyzed Arylcarbocyclization of Alkynes with Diaryliodonium Salts through C–C Bond Formation on Inert C_(sp3)–H Bond

  摘要：

  Copper-catalyzed arylcarbocyclization reaction of alkynes was realized with diaryliodonium salts through C-C bond formation on an inert C-(sp3)-H bond. This method provides an efficient cyclization of alkyl alkynes to generate carbocycles with good step-economy. Theoretical study revealed an interesting Cu-catalyzed concerted pathway of the C-C bond formation.

  DOI：

  10.1021/ol501655g
• 作为产物：
  描述：

  对甲酚 、 1,4-二碘苯 在 copper(l) iodide 、 iron(III)-acetylacetonate 、 potassium carbonate 作用下， 以 二甲基亚砜 为溶剂， 反应 5.0h， 以51%的产率得到1-碘-4-(4-甲基苯氧基)苯
  参考文献：
  名称：

  Cu-Catalyzed Arylcarbocyclization of Alkynes with Diaryliodonium Salts through C–C Bond Formation on Inert C_(sp3)–H Bond

  摘要：

  Copper-catalyzed arylcarbocyclization reaction of alkynes was realized with diaryliodonium salts through C-C bond formation on an inert C-(sp3)-H bond. This method provides an efficient cyclization of alkyl alkynes to generate carbocycles with good step-economy. Theoretical study revealed an interesting Cu-catalyzed concerted pathway of the C-C bond formation.

  DOI：

  10.1021/ol501655g

文献信息

• COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY
  申请人：Liu Hong

  公开号：US20100234365A1

  公开（公告）日：2010-09-16

  The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).

  本发明提供了化合物、包含这些化合物的制药组合物以及使用这些化合物治疗或预防与大麻素受体1（CB1）活性相关的疾病或障碍的方法。
• Alignment film, liquid crystal panel, and method for producing liquid crystal panel
  申请人：SHARP KABUSHIKI KAISHA

  公开号：US11156873B2

  公开（公告）日：2021-10-26

  The present invention provides an alignment film capable of reducing generation of bubbles in a liquid crystal layer, a liquid crystal panel including the alignment film, and a method for producing the liquid crystal panel. The alignment film contains at least one selected from the group consisting of a polyamic acid containing a bisaniline fluorene skeleton and a polyimide containing a bisaniline fluorene skeleton. Preferably, the bisaniline fluorene skeleton of the polyamic acid is contained in a diamine unit of the polyamic acid and the bisaniline fluorene skeleton of the polyimide is contained in a diamine unit of the polyimide.

  本发明提供了一种能够减少液晶层中气泡产生的对位膜、一种包括该对位膜的液晶面板以及一种生产该液晶面板的方法。对准膜包含至少一种选自包含双苯芴骨架的聚酰胺酸和包含双苯芴骨架的聚酰亚胺的组。优选地，聚氨基甲酸酯的比苯胺芴骨架包含在聚氨基甲酸酯的二胺单元中，而聚酰亚胺的比苯胺芴骨架包含在聚酰亚胺的二胺单元中。
• Liquid crystal alignment agent and liquid crystal panel
  申请人：SHARP KABUSHIKI KAISHA

  公开号：US11530357B2

  公开（公告）日：2022-12-20

  The present invention provides a liquid crystal alignment agent having high thermal stability and high solvent solubility, and a liquid crystal panel in which occurrence of ghosting and stain and a decrease in contrast are suppressed even under environments at high temperatures long period of time. The present invention is a liquid crystal alignment agent including a copolymer including a structure represented by a chemical formula (1) below, and a solvent. In the formula, X is a specified structure including a cyclic hydrocarbon group, Y 1 is a specified structure including a cyclic hydrocarbon group, R 1 represents a homogeneous alignment group, a homeotropic alignment group, or a photoreactive functional group, and Z 1 and Z 2 are the same or different, and represent an —NH— group, an —O— group, or a —S— group.

  本发明提供了一种具有高热稳定性和高溶剂溶解性的液晶配向剂，以及一种即使在长时间高温环境下也能抑制重影和污点的发生以及对比度下降的液晶面板。本发明是一种液晶配向剂，包括如下化学式（1）所示结构的共聚物和溶剂。式中，X 是包括环烃基团的特定结构，Y 1 是包括环烃基的指定结构，R 1 代表同性配位基团、同向配位基团或光活性官能团，Z 1 和 Z 2 代表-NH-基团、-O-基团或-S-基团。
• METHOD FOR PRODUCING OPTICAL MEMBER AND OPTICAL MEMBER FORMED BY THE PRODUCTION PROCESS
  申请人：Eiha Noriko

  公开号：US20100225013A1

  公开（公告）日：2010-09-09

  A method for producing an optical member from a nanocomposite material which includes a thermoplastic resin containing inorganic fine particles is provided. The method includes: a first step of preparing in a solution the thermoplastic resin containing the inorganic fine particles; a second step of drying and solidifying the solution containing the prepared thermoplastic resin to produce the nanocomposite material having a specific surface area (surface area/volume) of 15 mm −1 or more; and a third step of heat-compressing the produced nanocomposite material to form the optical member in a desired shape.
• ALIGNMENT FILM, LIQUID CRYSTAL PANEL, AND METHOD FOR PRODUCING LIQUID CRYSTAL PANEL
  申请人：SHARP KABUSHIKI KAISHA

  公开号：US20190079357A1

  公开（公告）日：2019-03-14

  The present invention provides an alignment film capable of reducing generation of bubbles in a liquid crystal layer, a liquid crystal panel including the alignment film, and a method for producing the liquid crystal panel. The alignment film contains at least one selected from the group consisting of a polyamic acid containing a bisaniline fluorene skeleton and a polyimide containing a bisaniline fluorene skeleton. Preferably, the bisaniline fluorene skeleton of the polyamic acid is contained in a diamine unit of the polyamic acid and the bisaniline fluorene skeleton of the polyimide is contained in a diamine unit of the polyimide.